LuAnne Morrow

October 09, 2025 - Big Pharma continues its hunt for innovation, and with uncertain market and regulatory conditions, some life sciences companies may be feeling the pressure to make their M&A exit or need additional funding in this tight financial market to progress their core asset to a value inflection point.

(October 09, 2025) - Joseph Kadlec, Douglas Gray and LuAnne Morrow of Troutman Pepper Locke explain how spin-offs and split-offs offer life sciences companies strategic alternatives to M&A for raising capital, reducing cash burn, and streamlining operations.

This article was originally published on July 14, 2025 on Retail TouchPoints and is republished here with permission. Taking your retail brand to the next level and attracting an equity investment based on the value of your brand requires not only business acumen but strategies for brand protection. Protecting your trademarks by way of registration is only a first step. Brand identity and value must also be protected by complying with consumer protection, privacy and advertising laws.